|
||||||||||||||||
|
||||||||||||||||
The following HTML text is provided to enhance online readability. Many aspects of typography translate only awkwardly to HTML. Please use the page image as the authoritative form to ensure accuracy. CER comparative effectiveness research CHOP cyclophosphamide, doxorubicin, vincristine, and prednisone CIRB central institutional review board CLL chronic lymphocytic leukemia CMS Centers for Medicare & Medicaid Services COG Children’s Oncology Group CRADA Cooperative Research and Development Agreement CRI Clinical Research Initiative (Association of American Cancer Institutes) CSDD Center for the Study of Drug Development CT computed tomography CTAC Clinical Trials Advisory Committee CTEP Cancer Therapy Evaluation Program CTMB Clinical Trials Monitoring Branch CTROC Clinical Trials and Translational Research Operations Committee CTSA Clinical and Translational Science Awards CTSU Cancer Trials Support Unit CTTI Clinical Trials Transformation Initiative CTU Clinical Trials Unit CTWG Clinical Trials Working Group CYP2D6 cytochrome P-450 2D6 DCE-MRI dynamic contrast-enhanced magnetic resonance imaging DCPC Division of Cancer Prevention and Control DCTD Division of Cancer Treatment and Diagnosis DCTDC Division of Cancer Treatment, Diagnosis, and Centers ECOG Eastern Cooperative Oncology Group EGFR epidermal growth factor receptor EMR electronic medical record EORTC European Organisation for Research and Treatment of Cancer ER estrogen receptor ERISA Employee Retirement Income Security Act of 1974 5-FU fluorouracil 18F-FDG fluorine-18 fluorodeoxyglucose FDA Food and Drug Administration FDAAA Food and Drug Administration Amendments Act of 2007 FNIH Foundation for the National Institutes of Health FOLFOX4 oxaliplatin, 5-fluorouracil, and leucovorin
|
|
|||||||||||||||
